Healthcare -
Biotechnology - NASDAQ - US
$ 0.549
-3.04 %
$ 30.4 M
Market Cap
-0.42
P/E
OMGA - COST OF REVENUE
Cost of Revenue OMGA - Omega Therapeutics, Inc.
65.9 M
LAST VALUE
589.13%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR